nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of the receptor tyrosine kinase RET improves long-term hematopoietic stem cell outgrowth and potency
|
Grey, W. |
|
|
136 |
22 |
p. 2535-2547 |
artikel |
2 |
Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy
|
Rosen, Steffen |
|
|
136 |
22 |
p. 2524-2534 |
artikel |
3 |
Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma
|
Jasielec, Jagoda K. |
|
|
136 |
22 |
p. 2513-2523 |
artikel |
4 |
Catch those antibodies before they fall
|
Shaz, Beth H. |
|
|
136 |
22 |
p. 2489-2490 |
artikel |
5 |
β-Catenin–TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation
|
Danek, Petr |
|
|
136 |
22 |
p. 2574-2587 |
artikel |
6 |
Editorial Board
|
|
|
|
136 |
22 |
p. i |
artikel |
7 |
Gene-produced FVIII: measure for measure
|
Ragni, Margaret |
|
|
136 |
22 |
p. 2483-2484 |
artikel |
8 |
How to manage CML patients with comorbidities
|
Cortes, Jorge |
|
|
136 |
22 |
p. 2507-2512 |
artikel |
9 |
Identifying potential germline variants from sequencing hematopoietic malignancies
|
Kraft, Ira L. |
|
|
136 |
22 |
p. 2498-2506 |
artikel |
10 |
Is the CNS-PINK the new CNS risk model in ENKTL?
|
Ellin, Fredrik |
|
|
136 |
22 |
p. 2486-2487 |
artikel |
11 |
Making a bet on RET for hematopoietic stem cell expansion
|
Hope, Kristin J. |
|
|
136 |
22 |
p. 2484-2486 |
artikel |
12 |
Metastatic nasopharyngeal carcinoma mimicking nodular sclerosis Hodgkin lymphoma
|
Liu, Huifei |
|
|
136 |
22 |
p. 2596 |
artikel |
13 |
MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma
|
Wang, Qiang |
|
|
136 |
22 |
p. 2557-2573 |
artikel |
14 |
MPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages
|
Nienhold, Ronny |
|
|
136 |
22 |
p. 2591-2595 |
artikel |
15 |
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphoma
|
Kim, Hyera |
|
|
136 |
22 |
p. 2548-2556 |
artikel |
16 |
Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset
|
Perreault, Josée |
|
|
136 |
22 |
p. 2588-2591 |
artikel |
17 |
What is the future of immunotherapy in multiple myeloma?
|
Rasche, Leo |
|
|
136 |
22 |
p. 2491-2497 |
artikel |
18 |
Wnt to the rescue! A new role in granulopoiesis
|
Boettcher, Steffen |
|
|
136 |
22 |
p. 2487-2489 |
artikel |